» Articles » PMID: 29228211

Asymmetry of Post-mortem Neuropathology in Behavioural-variant Frontotemporal Dementia

Overview
Journal Brain
Specialty Neurology
Date 2017 Dec 12
PMID 29228211
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Antemortem behavioural and anatomic abnormalities have largely been associated with right hemisphere disease in behavioural-variant frontotemporal dementia, but post-mortem neuropathological examination of bilateral hemispheres remains to be defined. Here we measured the severity of post-mortem pathology in both grey and white matter using a validated digital image analysis method in four cortical regions sampled from each hemisphere in 26 patients with behavioural-variant frontotemporal dementia, including those with frontotemporal degeneration (i.e. tau = 9, TDP-43 = 14, or FUS = 1 proteinopathy) or Alzheimer's pathology (n = 2). We calculated an asymmetry index based on the difference in measured pathology from each left-right sample pair. Analysis of the absolute value of the asymmetry index (i.e. degree of asymmetry independent of direction) revealed asymmetric pathology for both grey and white matter in all four regions sampled in frontototemporal degeneration patients with tau or TDP-43 pathology (P ≤ 0.01). Direct interhemispheric comparisons of regional pathology measurements within-subjects in the combined tauopathy and TDP-43 proteinopathy group found higher pathology in the right orbitofrontal grey matter compared to the left (P < 0.01) and increased pathology in ventrolateral temporal lobe grey matter of the left hemisphere compared to the right (P < 0.02). Preliminary group-wise comparisons between tauopathy and TDP-43 proteinopathy groups found differences in patterns of interhemispheric burden of grey and white matter regional pathology, with greater relative white matter pathology in tauopathies. To test the association of pathology measurement with ante-mortem observations, we performed exploratory analyses in the subset of patients with imaging data (n = 15) and found a direct association for increasing pathologic burden with decreasing cortical thickness in frontotemporal regions on ante-mortem imaging in tauopathy (P = 0.001) and a trend for TDP-43 proteinopathy (P = 0.06). Exploratory clinicopathological correlations demonstrated an association of socially-inappropriate behaviours with asymmetric right orbitofrontal grey matter pathology, and reduced semantically-guided category naming fluency was associated asymmetric white matter pathology in the left ventrolateral temporal region. We conclude that pathologic disease burden is distributed asymmetrically in behavioural-variant frontotemporal dementia, although not universally in the right hemisphere, and this asymmetry contributes to the clinical heterogeneity of the disorder. The basis for this asymmetric profile is enigmatic but may reflect distinct species or strains of tau and TDP-43 pathologies with propensities to spread by distinct cell- and region-specific mechanisms. Patterns of region-specific pathology in the right hemisphere as well as the left hemisphere may play a role in antemortem clinical observations, and these observations may contribute to antemortem identification of molecular pathology in frontotemporal degeneration.

Citing Articles

Neuropsychiatric and behavioral symptom clusters in frontotemporal dementia.

Sejourne C, Barker M, Heath M, Gazes Y, Fremont R, Perez Y J Alzheimers Dis Rep. 2025; 9:25424823251324391.

PMID: 40034531 PMC: 11873855. DOI: 10.1177/25424823251324391.


Disparate and shared transcriptomic signatures associated with cortical atrophy in genetic behavioral variant frontotemporal degeneration.

Shen T, Vogel J, Van Deerlin V, Suh E, Dratch L, Phillips J Mol Neurodegener. 2025; 20(1):17.

PMID: 39920674 PMC: 11806866. DOI: 10.1186/s13024-025-00806-3.


.

Pasternak M, Mirza S, Luciw N, Mutsaerts H, Petr J, Thomas D Alzheimers Dement. 2024; 20(5):3525-3542.

PMID: 38623902 PMC: 11095434. DOI: 10.1002/alz.13750.


Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias.

Kawles A, Keszycki R, Minogue G, Zouridakis A, Ayala I, Gill N Acta Neuropathol Commun. 2024; 12(1):31.

PMID: 38389095 PMC: 10885488. DOI: 10.1186/s40478-024-01738-7.


Evaluation of ATN Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease.

Cousins K, Irwin D, Tropea T, Rhodes E, Phillips J, Chen-Plotkin A Neurology. 2024; 102(4):e208033.

PMID: 38306599 PMC: 11383879. DOI: 10.1212/WNL.0000000000208033.


References
1.
Irwin D, Brettschneider J, McMillan C, Cooper F, Olm C, Arnold S . Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol. 2015; 79(2):272-87. PMC: 4755803. DOI: 10.1002/ana.24559. View

2.
Toledo J, Van Deerlin V, Lee E, Suh E, Baek Y, Robinson J . A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimers Dement. 2013; 10(4):477-484.e1. PMC: 3933464. DOI: 10.1016/j.jalz.2013.06.003. View

3.
Stefanits H, Budka H, Kovacs G . Asymmetry of neurodegenerative disease-related pathologies: a cautionary note. Acta Neuropathol. 2012; 123(3):449-52. DOI: 10.1007/s00401-011-0936-6. View

4.
Irwin D, Byrne M, McMillan C, Cooper F, Arnold S, Lee E . Semi-Automated Digital Image Analysis of Pick's Disease and TDP-43 Proteinopathy. J Histochem Cytochem. 2015; 64(1):54-66. PMC: 4810792. DOI: 10.1369/0022155415614303. View

5.
Ossenkoppele R, Pijnenburg Y, Perry D, Cohn-Sheehy B, Scheltens N, Vogel J . The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain. 2015; 138(Pt 9):2732-49. PMC: 4623840. DOI: 10.1093/brain/awv191. View